Search - tctmd.com

Displaying 301 - 320 of 375

Sort: Relevancy | Date

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

March 13, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Jason Kahn

March 06, 2012

News Daily News

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

March 06, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

El Estudio PEPCAD-DES: El Balón recubierto de Paclitaxel es mejor que el Balón convencional para resolver la reestenosis de un SLF

March 05, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Industry News

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

February 01, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

Advertisement

SES Effective for Both Focal, Diffuse DES Restenosis

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

El Estudio PEPCAD-DES: El Balón recubierto de Paclitaxel es mejor que el Balón convencional para resolver la reestenosis de un SLF

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

SCAAR: Second-Generation DES Improve Hard Outcomes

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Some New-Generation Stents Prone to Longitudinal Distortion

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

PRISM Individualized Informed Consent Improves PCI Choice, Experience

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Two New SES Show Improvement Over First-Generation Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content